EP Working Group on Access to Medicines and Poverty-Related Diseases

EP Working Group on Access to Medicines and Poverty-Related Diseases Putting Patient's Needs First: Supporting better innovation, access to medicines and healthcare to combat poverty-related diseases

The European Union has a major impact on access to medicines for developing countries, through its policies, legislation and bilateral and regional trade agreements. It is vital that the EU adopts appropriate measures that improve access to existing medical tools (medicines, diagnostics, vaccines) and that stimulate the research and development (R&D) of urgently-needed better tools for people in d

eveloping countries, notably for poverty-related diseases such as HIV/AIDS, tuberculosis and malaria. The Working Group operates as a Bureau of MEPs, with one Chair (David Martin - S&D) and four Co-Chairs (Kader Arif - S&D, Niccoló Rinaldi – ALDE, Carl Schlyter – Greens/EFA, Eleni Theocharous - EPP), and a Secretariat, formed by Médecins Sans Frontières’ Campaign for Access to Essential Medicines and Global Health Advocates. The Working Group is open to MEPs, academics, representatives from the European Commission, international organisations and civil society.

Adresse

Brussels

Téléphone

0032.2893.10.51

Site Web

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque EP Working Group on Access to Medicines and Poverty-Related Diseases publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager

Type